Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06508892 · ClinicalTrials.gov registry record
Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts
A clinical trial of Mass Screening, sponsored by University of Michigan.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06508892: Recruiting study of Mass Screening, sponsored by University of Michigan.
NCT06508892 is a study of Mass Screening that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06508892, a study of Mass Screening, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Creation and use of a smartphone application for older adults to assess the participants' risk of fall. Phase 1: Compare the accuracy and validity of accelerometer and gyroscopic data from a smartphone and gold-standard, wearable sensors gathered during balance and gait activities. Phase 2: Develop a model that integrates wearable sensor data and individual characteristics, such as age, medical conditions, exercises, previous falls, fear of falls, along with gait and balance outcome measurements, to evaluate fall risk in older adults. Phase 3: Integrate the computational model in the design of a mobile app for wearable devices for older adults to self-administer fall risk assessments and provide individualized risk of fall information.
Primary Outcome
Vertical, medial-lateral, and anterior-posterior acceleration
Conditions Studied
Interventions
- BEHAVIORAL risk of fall
Study Locations (1)
Michigan
- University of Michigan-Flint - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07-29 |
| Est. Completion | 2026-12-31 |
What NCT06508892 shows while recruiting
NCT06508892 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Mass Screening appearing as the primary indexed condition, and to 1 intervention - of which risk of fall is the first listed.
NCT06508892 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06508892 about?
NCT06508892 is a clinical study titled "Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts". Creation and use of a smartphone application for older adults to assess the participants' risk of fall. Phase 1: Compare the accuracy and validity of accelerometer and gyroscopic data from a smartphone and gold-standard, wearable sensors gathered during balance and gait activities. Phase 2: Develop ...
What is the current status of trial NCT06508892?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-07-29. Estimated completion is 2026-12-31.
What conditions does trial NCT06508892 study?
This clinical trial studies the following conditions: Mass Screening.
What interventions are being tested in trial NCT06508892?
The interventions under investigation include: risk of fall (BEHAVIORAL).
Who is sponsoring clinical trial NCT06508892?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06508892 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI